-
Foundations lag in giving to LGBTQ causes
24 Apr 2024 23:29 GMT
… Carter, who is queer and CEO of the Pride Foundation that … causes three years ago was Gilead Sciences Inc., which gave $53.3 …
-
NHS England and Gilead Sciences final push to eradicate hepatitis C with extended partnership
09 Apr 2024 15:09 GMT
This partnership aims to eliminate hepatitis C by 2025, aligning with global efforts to eradicate the virus and improve public health outcomes.
Since its inception in 2019, the Strategic Procurement agreement between Gilead, NHS England, and various …
-
Gilead Sciences CEO's compensation soars to new heights
19 Mar 2024 14:20 GMT
-
Gilead Sciences CEO on Company's Evolution and Commitment to the Bay Area
05 Mar 2024 15:31 GMT
… ;Day, chairman and CEO, arrived at Gilead Sciences in 2019. The company … from Gilead Sciences on 3blmedia.com.
Contact Info:
Spokesperson: Gilead Sciences
Website: … profiles/gilead-sciences
Email: info@3blmedia.com
SOURCE: Gilead Sciences
View the …
-
Jennifer Hudson and Orville Peck to Be Honored at GLAAD Media Awards in New York
23 Apr 2024 21:34 GMT
… powerful,” said GLAAD president and CEO Sarah Kate Ellis. “Most recently … New York is presented by Gilead Sciences and Hyundai Motor America, with …
-
In banner year, Lilly rewards CEO David Ricks with 24% boost in total pay to $26.6M
25 Mar 2024 21:28 GMT
… that its executives, led by CEO David Ricks, are raking in … 4 million in 2023, while Gilead Sciences CEO Daniel O'Day … four years before gaining the CEO post.
Accounting largely for … “Since assuming the role of CEO, Lilly has experienced revenue growth …
-
Gilead Sciences to acquire clinical─stage biopharma company, CymaBay Therapeutics for $4.3 billion
14 Feb 2024 04:46 GMT
… , chairman and chief executive officer, Gilead Sciences. “Building on the strong research … ,” said Sujal Shah, president, and CEO at CymaBay Therapeutics. “Now that … have high unmet medical need.
Gilead Sciences, Inc. is a biopharmaceutical company …
-
Gilead Sciences Buys CymaBay Therapeutics for $4.3B, Boosting Liver Disease Treatment Options
13 Feb 2024 18:54 GMT
Gilead Sciences has inked a deal to … 9, 2024, as reported by Gilead Sciences' press release.
"We … and CEO Daniel O’Day elaborated in a statement obtained by Gilead Sciences … in the press release from Gilead Sciences.
On a scientific note, seladelpar …
-
Gilead Sciences to acquire CymaBay Therapeutics for USD 4.3 billion
13 Feb 2024 10:03 GMT
Foster City: Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. … , Chairman and Chief Executive Officer, Gilead Sciences. “Building on the strong research … ,” said Sujal Shah, President, and CEO at CymaBay Therapeutics. “Now that …
-
Gilead Sciences Acquires CymaBay Therapeutics
12 Feb 2024 16:05 GMT
… candidate, seladelpar.
02.12.24
Gilead Sciences Inc. has entered a definitive … Daniel O’Day, Chairman and CEO, Gilead Sciences. “Building on the strong research … ,” said Sujal Shah, President, and CEO at CymaBay Therapeutics. “Now that …